# Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)

> **NCT00322543** · PHASE3 · TERMINATED · sponsor: **Conor Medsystems** · enrollment: 3 (actual)

## Conditions studied

- Coronary Disease

## Interventions

- **DEVICE:** Corio™ Pimecrolimus-eluting stent

## Key facts

- **NCT ID:** NCT00322543
- **Lead sponsor:** Conor Medsystems
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2006-05
- **Primary completion:** 2006-11
- **Final completion:** 2008-05
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2008-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00322543

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00322543, "Reduced Anti-Platelet Therapy With Pimecrolimus Drug Eluting Stent (RAPID)". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00322543. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*